Tarsus Pharmaceuticals Inc (TARS)
$74.85 +0.88% Close Oct 30, 2026 Live
Tarsus Pharmaceuticals stock today
Tarsus Pharmaceuticals closed at $74.85 on October 30, 2026, up 0.88% on the day. Over the past year it returned +8.5% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $3.22 billion.
$60.00$80.00
NovJan 2026MarMayJulSep
| Period | TARS | S&P 500 (SPY) |
|---|---|---|
| 1 month | -4.8% | -0.9% |
| 3 months | +25.7% | +2.1% |
| Year to date | -8.6% | +11.7% |
| 1 year | +8.5% | +12.4% |
| 3 years | +430.1% | +88.5% |
| 5 years | +169.6% | +76.0% |
Key statistics
- Market value
- $3.22B
- Price / sales
- 5.3
- 52-week range
- $56.11 to $90.78
- Next report
- Nov 3, 2026
About Tarsus Pharmaceuticals
Develops ophthalmologic pharmaceutical treatments.
Sector: Health Care
More on Tarsus Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue +147% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $2,696 today
No forecast, no recommendation. This page describes Tarsus Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.